Is there an optimal hemoglobin level for patients with glioblastoma multiforme?

Cancer Journal

Volumn 10, Issue 6, 2004, Pages 391-396

  Lally, Brian E ^a,b   Colasanto, Joseph M ^a,b   Fischer, James J ^a,b   Knisely, Jonathan P S ^a,b  

^a Yale University School of Medicine ^*

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Anemia; Glioblastoma; Hemoglobin; Hypoxia; Radiotherapy

Indexed keywords

HEMOGLOBIN;

ADULT; AGED; ARTICLE; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CONTROLLED STUDY; GLIOBLASTOMA; HEMOGLOBIN BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MULTIVARIATE ANALYSIS; OVERALL SURVIVAL; PATIENT SAFETY; PRIORITY JOURNAL; PROGNOSIS; RADIATION DOSE; TREATMENT DURATION; UNIVARIATE ANALYSIS; AGE; BLOOD; CENTRAL NERVOUS SYSTEM TUMOR; FEMALE; MALE; MIDDLE AGED; MORTALITY; UNITED STATES;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; CENTRAL NERVOUS SYSTEM NEOPLASMS; CONNECTICUT; FEMALE; GLIOBLASTOMA; HEMOGLOBINS; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROGNOSIS;

EID: 15744393423     PISSN: 15289117     EISSN: 1540336X     Source Type: Journal    
DOI: 10.1097/00130404-200411000-00010     Document Type: Article

References (24)

1. Kristiansen K, Hagen S, Kollevold T et al. Combined modality-therapy of operated astrocytomas grade III and IV: confirmation of the value of postoperative irradiation and lack of potentiation of bleomycin on survival time: a prospective multicenter trial of the Scandinavian Glioblastoma Study Group. Cancer 1981;47:649-652.
2. Scott CB, Scaranttno C, Urtasun R et al. Validation and predictive power of Radiation Therapy Oncology- Group (RTOG) recursive partitioning analysis classes for malignant glioma patients: a report using RTOG 90-06. Int J Radia Oncol Biol Phys 1998;40:51-55.
3. Walker MD, Alexander E Jr, Hunt WE et al. Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas: a cooperative clinical trial. J Neurosurg 1978;49:333-343.
4. Walker MD, Green SB, Byar DP et al. Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery. N Engl J Med 1980;303:1323-1329.
5. Fine HA, Dear KB, Loeffler JS et al. Meta-analysis of radiation therapy with and without adjuvant chemotherapy for malignant gliomas in adults. Cancer 1993;71:2585-2597.
6. Stenning SP, Freedman LS, Bleehen NM. An overview of published results from randomized studies of nitrosoureas in primary high grade malignant glioma. Br J Cancer 1987;56:89-90.
7. Stewart LA. Chemotherapy in adult high-grade glioma: a systematic review and meta-analysis of individual patient data from 12 randomised trials. Lancet 2002;359:1011-1018.
8. Collingridge DR, Piepmeier JM, Rockwell S et al. Polarographic measurements of oxygen tension in human glioma and surrounding peritumoural brain tissue. Radiother Oncol 1999;53:127-131.
9. Kayama T, Yoshimoto T, Fujimoto S et al. Intratumoral oxygen pressure in malignant brain tumor. J Neurosurg 1991;74:55-59.
10. 2 distribution and bioreductive enzymes in human malignant brain tumors. Int J Radiat Oncol Biol Phys 1994;29:427-431.
11. Odrazka K, Petera J, Kohlova T et al. Prognostic impact of hemoglobin level prior to radiotherapy on survival in patients with glioblastoma. Strahlenther Onkol 2003;179:615-619.
12. Brizel DM, Sibley GS, Prosnitz LR et al. Tumor hypoxia adversely affects the prognosis of carcinoma of the head and neck. Int J Radiat Oncol Biol Phys 1997;38:285-289.
13. Lee WR, Berkey B, Marcial V et al. Anemia is associated with decreased survival and increased locoregional failure in patients with locally advanced head and neck carcinoma: a secondary analysis of RTOG 85-27. Int J Radiat Oncol Biol Phys 1998;42:1069-1075.
14. Fein DA, Lee WR, Hanlon AL et al. Pretreatment hemoglobin level influences local control and survival of T1-T2 squamous cell carcinomas of the glottic larynx. J Clin Oncol 1995;13:2077-2083.
15. Warde P, O'Sullivan B, Bristow RG et al. T1/T2 glottic cancer managed by external beam radiotherapy: the influence of pretreatment hemoglobin on local control. Int J Radiat Oncol Biol Phys 1998;41:347-353.
16. Cho EI, Sasaki CT, Haffty BG. Prognostic significance of pretreatment hemoglobin for local control and overall survival in T1-T2N0 larynx cancer treated with external beam radiotherapy. Int J Radiat Oncol Biol Phys 2004;58:1135-1140.
17. Fyles AW, Milosevic M, Wong R et al. Oxygenation predicts radiation response and survival in patients with cervix cancer. Radiother Oncol 1998;48:149-156.
18. Hockel M, Schlenger K, Aral B et al. Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix. Cancer Res 1996;56:4509-4515.
19. Takeshi K, Katsuyuki K, Yoshiaki T et al. Definitive radiotherapy combined with high-dose-rate brachytherapy for stage III carcinoma of the uterine cervix: retrospective analysis of prognostic factors concerning patient characteristics and treatment parameters. Int J Radiat Oncol Biol Phys 1998;41:319-327.
20. Logsdon MD, Eifel PJ. FIGO IIIB squamous cell carcinoma of the cervix: an analysis of prognostic factors emphasizing the balance between external beam and intracavitary radiation therapy. Int J Radiat Oncol Biol Phys 1999;43:763-775.
21. Grogan M, Thomas GM, Melamed I et al. The importance of hemoglobin levels during radiotherapy for carcinoma of the cervix. Cancer 1999;86:1528-1536.
22. Molls M, Stadler P, Becker A et al. Relevance of oxygen in radiation oncology: mechanisms of action, correlation to low hemoglobin levels [review]. Strahlemher Onkol 1998;174[suppl 4]:13-16.
23. Henke M, Laszig R, Rube C et al. Erythropoietin to treat head and neck cancer patients with anaemia undergoing radiotherapy: randomised, double-blind, placebo-controlled trial. Lancet 2003;362:1255-1260.
24. Acs G, Zhang PJ, Rebbeck TR et al. Immunohistochemical expression of erythropoietin and erythropoietin receptor in breast carcinoma. Cancer 2002;95:969-981.